Zhejiang Haisen Pharmaceutical Co., Ltd.

61
Hold
  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE1000061L9
CNY
22.79
-0.53 (-2.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
467.00
393.00
420.00
385.00
282.00
263.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
467.00
393.00
420.00
385.00
282.00
263.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
93.00
73.00
69.00
44.00
34.00
31.00
Operating Expenses
0.00
0.00
0.00
0.00
0.00
0.00
General and Administration Expenses
40.00
32.00
29.00
30.00
24.00
41.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
346.00
289.00
314.00
279.00
210.00
191.00
Operating Profit (PBDIT) excl Other Income
120.00
103.00
106.00
106.00
71.00
72.00
Other Income
25.00
19.00
19.00
3.00
2.00
8.00
Operating Profit (PBDIT)
159.00
135.00
140.00
123.00
85.00
90.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
16.00
15.00
15.00
14.00
11.00
9.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
141.00
120.00
123.00
108.00
73.00
80.00
Provision for Tax
19.00
16.00
16.00
14.00
10.00
11.00
Profit After Tax
122.00
104.00
107.00
93.00
62.00
68.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.82
0.70
0.72
0.63
0.42
0.46
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 18.78% vs -6.50% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 16.36% vs -2.98% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 168.25% vs -34.24% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 17.09% vs -2.72% in Dec 2023

Compare Profit and Loss Results of Zhejiang Haisen Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
467.00
0
467.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
467.00
0
467.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
93.00
0
93.00
0%
Operating Expenses
0.00
0
0.00
0%
General and Administration Expenses
40.00
0
40.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
346.00
0
346.00
0%
Operating Profit (PBDIT) excl Other Income
120.00
0.00
120.00
0%
Other Income
25.00
0
25.00
0%
Operating Profit (PBDIT)
159.00
0
159.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
16.00
0
16.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
141.00
0
141.00
0%
Provision for Tax
19.00
0
19.00
0%
Profit After Tax
122.00
0
122.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.8228
0
0.82
0%
Profit And Loss - Net Sales
Net Sales 467.15 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 18.78% vs -6.50% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 120.25 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 16.36% vs -2.98% in Dec 2023

Profit And Loss - Interest
Interest 0.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 168.25% vs -34.24% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 122.56 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 17.09% vs -2.72% in Dec 2023